Litigation Details for Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-11-03 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
Jury Demand | None | Referred To | |
Patents | 8,791,122; 9,284,280 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Actelion Pharmaceuticals US, Inc. v. Cipla Ltd.
Details for Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-11-03 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122 ;9,284,280. (mpb) (… 3 November 2022 1:22-cv-01450 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2023-08-31 | 56 | Notice of Service | Initial Invalidity Contentions for U.S. Patent Nos. 8,791,122 and 9,284,280 filed by Alembic Pharmaceuticals… 3 November 2022 1:22-cv-01450 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |